An interim analysis of phase 3 trials published in The Lancet on Tuesday suggests that Sputnik V is 91.6% effective at preventing symptomatic COVID-19.
The peer-reviewed analysis published Tuesday, however, was based on a group of nearly 15,000 people who received the Sputnik V doses.
Prime Minister of Russia
President of Russia
Documentaries, videos and podcasts
A brief history of Russia in 50 minutes.
March 23, 2017